The use of rhDNAse in severely ill, non-intubated adult asthmatics refractory to bronchodilators: A pilot study
Authors:
- Robert A. SilvermanRSRobert A. Silverman
- Finbar FoleyFFFinbar Foley
- Resul DalipiRDResul Dalipi
- Myriam KlineMKMyriam Kline
- Martin LesserMLMartin Lesser
- 1 August 2012
- journal article
- research article
- Published by Elsevier in Respiratory Medicine
- Vol. 106 (8) , 1096-1102
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Recombinant human deoxyribonuclease for the treatment of acute asthma in childrenThorax, 2007
- FEV 1 Performance Among Patients With Acute AsthmaChest, 2007
- Standardisation of spirometryEuropean Respiratory Journal, 2005
- Characterization of airway plugging in fatal asthmaThe American Journal of Medicine, 2003
- IV Magnesium Sulfate in the Treatment of Acute Severe AsthmaChest, 2002
- Intratracheal recombinant human deoxyribonuclease in acute life-threatening asthma refractory to conventional treatmentBritish Journal of Anaesthesia, 2000
- Resolution of mucus plugging and atelectasis after intratracheal rhDNase therapy in a mechanically ventilated child with refractory status asthmaticusCritical Care Medicine, 2000
- Sudden‐onset Severe Acute Asthma: Clinical Features and Response to TherapyAcademic Emergency Medicine, 1998
- Human recombinant DNase for mucus plugging in status asthmaticusThe Lancet, 1995
- Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic FibrosisNew England Journal of Medicine, 1994